Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review

Colorectal cancer (CRC) is second most commonly diagnosed cancer in women and third in men and is responsible for almost 0.7 million deaths annually worldwide. (Torre et al., 2015) Recent data suggests a shift in incidence with a decreasing trend in patients over 50, and an increasing trend in those below 50. (Davis et al., 2011; Siegel et al., 2017) Early detection of CRC is associated with 5-year survival rates as high as 93% in patients staged T1/2N0M0. However, over 20% of patients present with metastatic disease at diagnosis, and up to half surgically radically treated patients will develop metastases.
Source: Critical Reviews in Oncology Hematology - Category: Cancer & Oncology Authors: Source Type: research